Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends
- PMID: 21238514
- PMCID: PMC3436072
- DOI: 10.1016/j.jconrel.2011.01.006
Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends
Abstract
The use of ultrasound for the delivery of drugs to, or through, the skin is commonly known as sonophoresis or phonophoresis. The use of therapeutic and high frequencies of ultrasound (≥0.7MHz) for sonophoresis (HFS) dates back to as early as the 1950s, while low-frequency sonophoresis (LFS, 20-100kHz) has only been investigated significantly during the past two decades. Although HFS and LFS are similar because they both utilize ultrasound to increase the skin penetration of permeants, the mechanisms associated with each physical enhancer are different. Specifically, the location of cavitation and the extent to which each process can increase skin permeability are quite dissimilar. Although the applications of both technologies are different, they each have strengths that could allow them to improve current methods of local, regional, and systemic drug delivery. In this review, we will discuss the mechanisms associated with both HFS and LFS, specifically concentrating on the key mechanistic differences between these two skin treatment methods. Background on the relevant physics associated with ultrasound transmitted through aqueous media will also be discussed, along with implications of these phenomena on sonophoresis. Finally, a thorough review of the literature is included, dating back to the first published reports of sonophoresis, including a discussion of emerging trends in the field.
Copyright © 2011 Elsevier B.V. All rights reserved.
Figures
), cavitation bubbles (
), lipid bilayers (
), and coupling medium (
).
), lipid bilayers (
), and coupling medium (
).
Similar articles
-
Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs.Expert Opin Drug Deliv. 2010 Dec;7(12):1415-32. doi: 10.1517/17425247.2010.538679. Expert Opin Drug Deliv. 2010. PMID: 21118031 Free PMC article. Review.
-
Dependence of low-frequency sonophoresis on ultrasound parameters; distance of the horn and intensity.Int J Pharm. 2002 Mar 20;235(1-2):35-42. doi: 10.1016/s0378-5173(01)00981-4. Int J Pharm. 2002. PMID: 11879737
-
Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis.J Pharm Sci. 2001 May;90(5):545-68. doi: 10.1002/1520-6017(200105)90:5<545::aid-jps1012>3.0.co;2-h. J Pharm Sci. 2001. PMID: 11288100
-
Low-frequency sonophoresis: current status and future prospects.Adv Drug Deliv Rev. 2008 Jun 30;60(10):1218-23. doi: 10.1016/j.addr.2008.03.006. Epub 2008 Apr 3. Adv Drug Deliv Rev. 2008. PMID: 18450318 Review.
-
Sonophoresis: recent advancements and future trends.J Pharm Pharmacol. 2009 Jun;61(6):689-705. doi: 10.1211/jpp.61.06.0001. J Pharm Pharmacol. 2009. PMID: 19505359 Review.
Cited by
-
The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review.Am J Clin Dermatol. 2024 Nov;25(6):951-966. doi: 10.1007/s40257-024-00891-y. Epub 2024 Oct 5. Am J Clin Dermatol. 2024. PMID: 39369127 Free PMC article. Review.
-
Bibliometric and visualized analysis of ultrasound combined with microbubble therapy technology from 2009 to 2023.Front Pharmacol. 2024 Jul 25;15:1418142. doi: 10.3389/fphar.2024.1418142. eCollection 2024. Front Pharmacol. 2024. PMID: 39119614 Free PMC article. Review.
-
A piezoelectric-driven microneedle platform for skin disease therapy.Innovation (Camb). 2024 Apr 5;5(3):100621. doi: 10.1016/j.xinn.2024.100621. eCollection 2024 May 6. Innovation (Camb). 2024. PMID: 38680817 Free PMC article.
-
Transdermal Drug Delivery Systems: A Focused Review of the Physical Methods of Permeation Enhancement.Adv Pharm Bull. 2024 Mar;14(1):67-85. doi: 10.34172/apb.2024.018. Epub 2023 Oct 14. Adv Pharm Bull. 2024. PMID: 38585458 Free PMC article. Review.
-
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system.Adv Drug Deliv Rev. 2024 May;208:115275. doi: 10.1016/j.addr.2024.115275. Epub 2024 Mar 3. Adv Drug Deliv Rev. 2024. PMID: 38442747 Review.
References
-
- Mitragotri S. Sonophoresis: a 50-year journey. Drug Discov Today. 2004;9(17):735–736. - PubMed
-
- Fellinger K, Schmid J. Klinik und Therapie des chronischen Gelenkrheumatismus. Maudrich, Vienna, Austria: 1954.
-
- Newman M, Kill M, Frampton G. Effects of ultrasound alone and combined with hydrocortisone injections by needle or hypo-spray. Amer J Physical Med. 1958;37(4):206–209. - PubMed
-
- Tyle P, Agrawala P. Drug delivery by phonophoresis. Pharm Res. 1989;6(5):355–361. - PubMed
-
- Bommannan D, Menon G, Okuyama H, Elias P, Guy R. Sonophoresis. II. Examination of the mechanism (s) of ultrasound-enhanced transdermal drug delivery. Pharm Res. 1992;9(8):1043–1047. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
